Publications (8) MIRYAN GÓMEZ ROSO publications

2019

  1. Fluoxetine oral treatment discloses 5-HT 1D receptor as vagoinhibitor of the cardiac cholinergic neurotransmission in rat

    Canadian Journal of Physiology and Pharmacology, Vol. 97, Núm. 2, pp. 90-98

  2. Hypertension exhibits 5-HT 4 receptor as a modulator of sympathetic neurotransmission in the rat mesenteric vasculature

    Hypertension Research, Vol. 42, Núm. 5, pp. 618-627

2017

  1. 5-HT modulates the rat mesenteric vasopressor outflow by 5-HT1D sympatholytic receptors

    Clinical and Experimental Pharmacology and Physiology, Vol. 44, Núm. 12, pp. 1224-1231

2016

  1. Zofenopril exerts a cardiovascular protective effect on rats infused with angiotensin II beyond angiotensin-converting enzyme inhibition

    Journal of Pharmacy and Pharmacology, Vol. 68, Núm. 11, pp. 1422-1429

2014

  1. Zofenopril evita las alteraciones cardiovasculares en ratones con infusión de Ang II

    Revista en Actualidad en Farmacología y Terapéutica

2009

  1. Cardiovascular changes in spontaneously hypertensive rats are improved by chronic treatment with zofenopril

    British Journal of Pharmacology, Vol. 158, Núm. 8, pp. 1911-1921

2008

  1. HEPATOPROTECTIVE EFFECTS OF OMETRIX (R) ON OXIDATIVE DAMAGE INDUCED BY tert-BUTYL HYDROPEROXIDE IN RATS

    METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY

2005

  1. Astaxantina mejora la función endotelial, la estructura vascular y el estado redox en SHR: XXVII Congreso nacional de la SEF

    Actualidad en farmacología y terapéutica, Vol. 3, Núm. 4, pp. 301-302